Company news
Bio-Gene Technology Ltd. news in 2025
Bio-Gene Technology Ltd.'s news releases, calls and decks from 2025, newest first.
U.S. Department of Defense Grant Programs Advance
December 17, 2025
Bio-Gene Receives $519,500 R&D Tax Incentive
November 24, 2025
CEO's Presentation
November 19, 2025
Chair's Address to Shareholders
November 19, 2025
Qcide receives organic listing status in USA
November 13, 2025
Response to ASX Aware Letter
September 29, 2025
Positive Flavocide Efficacy Results Presented
September 22, 2025
Appendix 4E and 2025 Annual Report
August 25, 2025
Result of Security Purchase Plan
June 2, 2025
Launch of Security Purchase Plan
May 12, 2025
Investor Presentation - Placement
May 5, 2025
Result of Placement
May 5, 2025
Trading Halt
April 30, 2025
Bio-Gene Presentation - NWR Virtual Healthcare Conference
March 19, 2025
Appendix 4D and Half-Year Accounts 31 December 2024
February 27, 2025
BGT Investor Webinar 4-Feb-25 Slides
February 3, 2025
BGT Awarded U.S. Department of Defense Grants
January 28, 2025
Decks in 2025
- Shareholder Meeting (November 2025)
Shareholder meeting · 15 slides · Nov 19, 2025
- Investor Presentation (May 2025)
Investor deck · 24 slides · May 5, 2025
- NWR Virtual Healthcare Conference 2025
Conference · 25 slides · Mar 20, 2025
- Investor Presentation (February 2025)
Investor deck · 7 slides · Feb 4, 2025